DNAprint Genomics (DNAG)

[frogdreaming]

gunnabe, Calm down.

I apologize for going too fast for you.

You asked if the 4% discount being taken by Dutchess was a positive indicator when compared to the 20% discount given to LaJolla.

I replied by suggesting that the two companies were playing different roles (one a simple low risk share exchanger providing funds to DNAP, the other a player in the actual ownership of the company) and therefore the comparison was invalid. I also offered a viewpoint that suggested that the indicator was negative.

Your rejoinder ignored the differences that I had pointed out and further suggested that my response could be spun as evidence for your premise.

I then attempted to show how Dutchess's involvement was much more easily characterized as ownership as opposed to low risk financing effort being performed by LaJolla. I compared the behavior of DNAP in its acquisition of Biofrontera to the similar effort undertaken by Dutchess. I was staying entirely ON topic and the discussion was a direct result of the previous posts in the thread.

Forgive me for assuming that you were capable of keeping up. I won't make the same mistake again.

regards,
frog